Simple blood test may reveal if cancer treatment is working
NCT ID NCT05914961
Summary
This study aims to see if tracking a common inflammation marker (CRP) in the blood can predict how well patients with triple-negative breast cancer respond to immunotherapy. It will observe 225 patients already receiving standard immunotherapy and chemotherapy. The goal is to find a simple, routine blood test that helps doctors know sooner if a treatment is effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Women's Health
RECRUITINGTübingen, 72076, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.